LentiPeak™: Robust, Scalable, And Suspension Based Platform Redefining Lentiviral Vector Manufacturing

A Customizable Platform, Designed to Meet Your Needs

Our proprietary LentiPeak™ lentiviral vector platform offers:

• Serum-free, transient transfection, HEK293 based process
• Third-generation LV plasmid system
• High functional titers ranging from 1x10^8 to 1x10^9 TU/mL
• Proven platform performance with various CAR and TCR constructs at multiple production scales
• Integrated analytical support with panels of established testing methods in-house
• Efficient supply chain management and risk mitigation
• Streamlined Tech Transfer between PD and cGMP manufacturing with aligned unit operations, equipment, bill of materials and analytics
• Pre-established cGMP documentation and trained technical team
• Available cGMP capacity without waiting time
• Comprehensive regulatory support package
• Parallel development with cell processing activities for ex-vivo programs